Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia
Abstract
1. Introduction
2. Material and Method
2.1. Cases Presentation
2.2. Final Diagnosis
Treatment
2.3. Follow-Up and Outcome
3. Discussion
4. Limitations and Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Mégarbane, B.; Borron, S.W.; Baud, F.J. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med. 2005, 31, 189–195. [Google Scholar] [CrossRef]
- Kraut, J.A.; Kurtz, I. Toxic alcohol ingestions: Clinical features, diagnosis, and management. Clin. J. Am. Soc. Nephrol. 2008, 3, 208–225. [Google Scholar] [CrossRef]
- Galvez-Ruiz, A.; Elkhamary, S.M.; Asghar, N.; Bosley, T.M. Visual and neurologic sequelae of methanol poisoning in Saudi Arabia. Saudi Med. J. 2015, 36, 568–574. [Google Scholar] [CrossRef]
- Manning, L.; Kowalska, A. Illicit alcohol: Public health risk of methanol poisoning and policy mitigation strategies. Foods 2021, 10, 1625. [Google Scholar] [CrossRef] [PubMed]
- Edenberg, H.J. The genetics of alcohol metabolism: Role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res. Health 2007, 30, 5–13. [Google Scholar]
- Gouda, A.S.; Khattab, A.M.; Mégarbane, B. Lessons from a methanol poisoning outbreak in Egypt: Six case reports. World J. Crit. Care Med. 2020, 9, 54. [Google Scholar] [CrossRef]
- Kraut, J.A.; Mullins, M.E. Toxic Alcohols. N. Engl. J. Med. 2018, 378, 270–280. [Google Scholar] [CrossRef]
- Paasma, R.; Hovda, K.E.; Jacobsen, D. Methanol poisoning and long term sequelae 2014—A six years follow-up after a large methanol outbreak. BMC Clin. Pharm. 2009, 9, 5. [Google Scholar] [CrossRef]
- Hovda, K.E.; Hunderi, O.H.; Tafjord, A.B.; Dunlop, O.; Rudberg, N.; Jacobsen, D. Methanol outbreak in Norway 2002–2004: Epidemiology, clinical features and prognostic signs. J. Intern. Med. 2005, 258, 181–190. [Google Scholar] [CrossRef]
- Moon, C.-S. Estimations of the lethal and exposure doses for representative methanol symptoms in humans. Ann. Occup. Environ. Med. 2017, 29, 44. [Google Scholar] [CrossRef]
- Nekoukar, Z.; Zakariaei, Z.; Taghizadeh, F.; Musavi, F.; Banimostafavi, E.S.; Sharifpour, A.; Ebrahim Ghuchi, N.; Fakhar, M.; Tabaripour, R.; Safanavaei, S. Methanol poisoning as a new world challenge: A review. Ann. Med. Surg. 2021, 66, 102445. [Google Scholar] [CrossRef]
- Roberts, D.M.; Yates, C.; Megarbane, B.; Winchester, J.F.; Maclaren, R.; Gosselin, S.; Nolin, T.D.; Lavergne, V.; Hoffman, R.S.; Ghannoum, M. Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: A systematic review and consensus statement. Crit. Care Med. 2015, 43, 461–472. [Google Scholar] [CrossRef]
- Hassanian-Moghaddam, H.; Nikfarjam, A.; Mirafzal, A.; Saberinia, A.; Nasehi, A.A.; Masoumi Asl, H.; Memaryan, N. Methanol mass poisoning in Iran: Role of case finding in outbreak management. J. Public Health 2015, 37, 354–359. [Google Scholar] [CrossRef]
- Hovda, K.E.; Hunderi, O.H.; Rudberg, N.; Froyshov, S.; Jacobsen, D. Anion and osmolal gaps in the diagnosis of methanol poisoning: Clinical study in 28 patients. Intensive Care Med. 2004, 30, 1842–1846. [Google Scholar] [CrossRef] [PubMed]
- Martín-Calderón, J.L.; Bustos, F.; Tuesta-Reina, L.R.; Varona, J.M.; Caballero, L.; Solano, F. Choice of the best equation for plasma osmolality calculation: Comparison of fourteen formulae. Clin. Biochem. 2015, 48, 529–533. [Google Scholar] [CrossRef]
- Shafi, H.; Imran, M.; Usman, H.F.; Sarwar, M.; Tahir, M.A. Eight fatalities due to drinking methanol-tainted alcohol in Pakistan: A case report. Egypt. J. Forensic Sci. 2016, 6, 515–519. [Google Scholar] [CrossRef]
- Rahimi, R.; Zainun, K.A.; Noor, N.M.; Kasim, N.A.M.; Shahrir, N.F.; Azman, N.A.; Elankopan, R.; Nikman, K.A.; Room, N.H.M. Methanol poisoning in Klang Valley, Malaysia: Autopsy case series. Forensic Sci. Int. Rep. 2021, 3, 100170. [Google Scholar] [CrossRef]
- Brahmi, N.; Blel, Y.; Abidi, N.; Kouraichi, N.; Thabet, H.; Hedhili, A.; Amamou, M. Methanol poisoning in Tunisia: Report of 16 cases. Clin. Toxicol. 2007, 45, 717–720. [Google Scholar] [CrossRef]
- Md Noor, J.; Hawari, R.; Mokhtar, M.F.; Yussof, S.J.; Chew, N.; Norzan, N.A.; Rahimi, R.; Ismail, Z.; Singh, S.; Baladas, J.; et al. Methanol outbreak: A Malaysian tertiary hospital experience. Int. J. Emerg. Med. 2020, 13, 6. [Google Scholar] [CrossRef]
- Eskandrani, R.; Almulhim, K.; Altamimi, A.; Alhaj, A.; Alnasser, S.; Alawi, L.; Aldweikh, E.; Alaufi, K.; Mzahim, B. Methanol poisoning outbreak in Saudi Arabia: A case series. J. Med. Case Rep. 2022, 16, 357. [Google Scholar] [CrossRef]
- Paasma, R.; Hovda, K.E.; Tikkerberi, A.; Jacobsen, D. Methanol mass poisoning in Estonia: Outbreak in 154 patients. Clin. Toxicol. 2007, 45, 152–157. [Google Scholar] [CrossRef]
- Sodhi, P.K.; Goyal, J.L.; Mehta, D.K. Methanol-induced optic neuropathy: Treatment with intravenous high dose steroids. Int. J. Clin. Pract. 2001, 55, 599–602. [Google Scholar] [CrossRef]
- Desai, T.; Sudhalkar, A.; Vyas, U.; Khamar, B. Methanol poisoning: Predictors of visual outcomes. JAMA Ophthalmol. 2013, 131, 358–364. [Google Scholar] [CrossRef]
- Simani, L.; Ramezani, M.; Roozbeh, M.; Shadnia, S.; Pakdaman, H. The outbreak of methanol intoxication during COVID-19 pandemic: Prevalence of brain lesions and its predisposing factors. Drug Chem. Toxicol. 2020, 45, 1500–1503. [Google Scholar] [CrossRef]
- National Center for Biotechnology Information. “PubChem Compound Summary for CID 887, Methanol” PubChem. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Methanol (accessed on 28 May 2023).
- American Academy of Clinical Toxicology Ad Hoc Committee on the Treatment Guidelines for Methanol Poisoning; Barceloux, D.G.; Randall Bond, G.; Krenzelok, E.P.; Cooper, H.; Allister Vale, J. American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Methanol Poisoning. J. Toxicol. Clin. Toxicol. 2002, 40, 415–446. [Google Scholar] [CrossRef]
- Brubaker, R.H.; Vashisht, R.; Meseeha, M. High Anion Gap Metabolic Acidosis. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2023. [Google Scholar]
- Najari, F.; Baradaran, I.; Najari, D. Methanol Poisoning and Its Treatment. Int. J. Med. Toxicol. Forensic Med. 2020, 10, 26639. [Google Scholar] [CrossRef]
- Holzman, S.D.; Larsen, J.; Kaur, R.; Smelski, G.; Dudley, S.; Shirazi, F.M. Death by hand sanitizer: Syndemic methanol poisoning in the age of COVID-19. Clin. Toxicol. 2021, 59, 1009–1014. [Google Scholar] [CrossRef]
- Brent, J. Fomepizole for ethylene glycol and methanol poisoning. N. Engl. J. Med. 2009, 360, 2216–2223. [Google Scholar] [CrossRef]
- Rietjens, S.J.; De Lange, D.W.; Meulenbelt, J. Ethylene glycol or methanol intoxication: Which antidote should be used, fomepizole or ethanol. Neth. J. Med. 2014, 72, 73–79. [Google Scholar]
- McMartin, K.; Jacobsen, D.; Hovda, K.E. Antidotes for poisoning by alcohols that form toxic metabolites. Br. J. Clin. Pharmacol. 2016, 81, 505–515. [Google Scholar] [CrossRef]
- Ashurst, J.V.; Nappe, T.M. Methanol Toxicity. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2023. [Google Scholar]
- Chan, A.P.L.; Chan, T.Y.K. Methanol as an Unlisted Ingredient in Supposedly Alcohol-Based Hand Rub Can Pose Serious Health Risk. Int. J. Env. Res. Public Health 2018, 15, 1440. [Google Scholar] [CrossRef]
- Holt, N.R.; Nickson, C.P. Severe methanol poisoning with neurological sequelae: Implications for diagnosis and management. Intern Med. J. 2018, 48, 335–339. [Google Scholar] [CrossRef]
- Jobard, E.; Harry, P.; Turcant, A.; Marie Roy, P.; Allain, P. 4-Methylpyrazole and hemodialysis in ethylene glycol poisoning. J. Toxicol. Clin. Toxicol. 1996, 34, 373–377. [Google Scholar] [CrossRef]
- Chen, T.-H.; Kuo, C.-H.; Huang, C.-T.; Wang, W.-L. Use of Fomepizole in Pediatric Methanol Exposure: The First Case Report in Taiwan and a Literature Review. Pediatr. Neonatol. 2016, 57, 351–354. [Google Scholar] [CrossRef]
- Ukita, K.; Otomune, K.; Fujimoto, R.; Hasegawa, K.; Izumikawa, K.; Morimoto, N.; Sasaki, K.; Hirasaki, A.; Takaguchi, K. Anion gap-opening metabolic acidosis and urinary findings in the early diagnosis of ethylene glycol poisoning: A case report. Clin. Case Rep. 2022, 10, e05215. [Google Scholar] [CrossRef]
- Kute, V.B.; Godara, S.M.; Shah, P.R.; Gumber, M.R.; Goplani, K.R.; Vanikar, A.V.; Munjappa, B.C.; Patel, H.V.; Trivedi, H.L. Hemodialysis for methyl alcohol poisoning: A single-center experience. Saudi J. Kidney Dis. Transpl. 2012, 23, 37–43. [Google Scholar]
- Mirrakhimov, A.E.; Ayach, T.; Barbaryan, A.; Talari, G.; Chadha, R.; Gray, A. The Role of Sodium Bicarbonate in the Management of Some Toxic Ingestions. Int. J. Nephrol. 2017, 2017, 7831358. [Google Scholar] [CrossRef]
- Williams, G.F.; Hatch, F.J.; Bradley, M.C. Methanol poisoning: A review and case study of four patients from Central Australia. Aust. Crit. Care 1997, 10, 113–118. [Google Scholar] [CrossRef]
- Sevimli, H.; Yönak, H.; Beleli, G.; Akça, H.Ş.; Özdemir, S.; Algın, A.; Eroğlu, S.E. Death also have color, this time purple; Methanol. Balıkesir Med. J. 2020, 4, 29–33. [Google Scholar] [CrossRef]
- Mallick, U.K.; Shahid, S.M.H.; Faruq, M.O.; Asaduzzaman, M.; Sultana, A.; Asha, A. Rrefractory Metabolic Acidosis in a Diabetic Patient: A case of Unsuspected Methanol Intoxication. Bangladesh Crit. Care J. 2019, 7, 111–112. [Google Scholar] [CrossRef]
- Zakharov, S.; Pelclova, D.; Urban, P.; Navratil, T.; Nurieva, O.; Kotikova, K.; Diblik, P.; Kurcova, I.; Belacek, J.; Komarc, M. Use of out-of-hospital ethanol administration to improve outcome in mass methanol outbreaks. Ann. Emerg. Med. 2016, 68, 52–61. [Google Scholar] [CrossRef]
- Nurieva, O.; Hubacek, J.A.; Urban, P.; Hlusicka, J.; Diblik, P.; Kuthan, P.; Sklenka, P.; Meliska, M.; Bydzovsky, J.; Heissigerova, J. Clinical and genetic determinants of chronic visual pathway changes after methanol-induced optic neuropathy: Four-year follow-up study. Clin. Toxicol. 2019, 57, 387–397. [Google Scholar] [CrossRef]
- Zakharov, S.; Pelclova, D.; Diblik, P.; Urban, P.; Kuthan, P.; Nurieva, O.; Kotikova, K.; Navratil, T.; Komarc, M.; Belacek, J. Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients. Clin. Toxicol. 2015, 53, 884–892. [Google Scholar] [CrossRef]
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
Gender | Male | Male | Male | Male | Male | Male |
Age in years | 43 | 26 | 44 | 41 | 32 | 30 |
Nationality | Saudi | Indian | Saudi | Nepalese | Indian | Indian |
Hospital admission date | 16 November 2022 | 16 November 2022 | 16 November 2022 | 4 March 2022 | 4 March 2022 | 4 March 2022 |
Hospital duration | 10 h | 12 h | 10 h | 5 d | 3 d | 3 d |
Exposure | Alcohol history | Alcohol history | Colonia ingestion | Alcohol ingestion (colonia) | Alcohol ingestion | Alcohol ingestion (colonia) |
Methanol poisoning | Yes | Yes | Yes | Yes | Yes | Yes |
Methanol level (mg/dL) | NA | 275 | NA | NA | NA | NA |
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
Pulse (beats/min) | 101 | 80 | 138 | 62 | 96 | 82 |
RR (respirations/min) | 20 | 20 | 22 | 20 | 20 | 20 |
BP (mm.Hg) | 79/64 | 98/48 | 170/116 | 133/90 | 143/87 | 145/95 |
Temp (°C) | 37 | 37 | 34.7 | 36.6 | 36.6 | 38.2 |
SPO2 (%) | 100 | 100 | 99 | 90 | 96 | 95 |
PCO2 (mm.Hg) | 45.9 | 54.2 | 19 | 36.4 | 28 | 25 |
Arterial pH | 6.56 | 6.8 | 7 | 7.19 | 7.1 | 7.1 |
HCO3 (mmol/L) | 1.7 | 1 | 4 | 10 | 11.2 | 8.5 |
TLC | 18.8 | 8.47 | NA | NA | NA | NA |
Hgb (g/dL) | 14.8 | 16 | 16.4 | 13 | 17.1 | 16 |
WBC (g/L) | 18.8 | 12.24 | 11.9 | 6.34 | 14.1 | 17 |
PLT (g/L) | 206 | 151 | 342 | 355 | 307 | 389 |
INR | 1.1 | NA | 1.1 | 1.14 | 1.08 | NA |
AST (U/L) | 173 | 446 | 48 | 41 | 35 | 19 |
ALT (U/L) | 82 | 116 | 81 | 59 | 29 | 12 |
ALP (U/L) | 106 | 61 | 109 | NA | 103 | 109 |
Direct bilirubin (mg/dL) | 0.16 | 0.46 | 0.14 | 0.2 | 0.2 | 0.3 |
T.protein (g/dL) | 5.9 | 5 | NA | 6.3 | 6.6 | 6.6 |
Albumin (g/dL) | 3.6 | 2.6 | 3.7 | 3.5 | 3.5 | 3.6 |
T.bilirubin (mg/dL) | 0.2 | 0.6 | 0.3 | 0.7 | 0.7 | 0.7 |
λGT (U/L) | 111 | 155 | NA | 137 | 30 | 58 |
RBS (mg/dL) | 151 | 207 | 261 | 117 (FBS) | 64 | 81 |
LDH (U/L) | 510 | NA | 250 | NA | NA | NA |
Mg (mg/dL) | NA | 2.55 | 1.59 | NA | NA | 1.7 |
Ca (mg/dL) | 7.8 | 9.4 | 9.1 | 8.4 | 5.8 | 8.6 |
Na (mmol/L) | 142 | 160 | 143 | 139 | 134 | 142 |
K (mmol/L) | 4.4 | 1.4 | 3.2 | 3.4 | 3.2 | 3.2 |
Cl (mmol/L) | 111 | 122 | 109 | 107 | 103 | 113 |
Osmolality serum (Mosmol/kg) | 283.5 | 312 | 329 | 274.85 | 260.7 | 283.9 |
Cr (mg/dL) | 1.36 | 1.38 | 1.11 | 0.7 | 0.73 | 0.77 |
Urea (mg/dL) | 27.82 | 27.8 | 26.2 | 14.98 | 34 | 23.54 |
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
Eye: | ||||||
| Dilated | Dilated | Dilated | Dilated with sluggish response | Dilated | Dilated |
| Visual loss | Non-reactive to light | Lost left eye | Toxic optic nerve damage | Toxic optic nerve damage | Toxic optic nerve damage and blurred vision |
Heart | Arrest | Arrest | Tachycardia, arrest | Normal | Normal | Normal |
Respiratory | Normal | Mechanical ventilation | Gasping breath, arrest | Normal | Normal | Normal |
Temp | Normal | Normal | Hypothermic | Normal | Normal | Fever |
Metabolic acidosis | Yes | Yes | Yes | Yes | Yes | Yes |
Abdomen | Normal | Soft, no megally | Pain, soft, coffee vomit | Soft lax | Soft lax, epigastric pain, vomiting | Soft lax |
Kidney | Acute renal failure | NA | NA | NA | NA | NA |
CNS: | ||||||
| Diffused edema, anorexic damage | Normal | Normal | Normal | Normal | Normal |
| Yes | Yes | Yes | Yes | Yes | Yes |
| NA | Yes | Yes | NA | NA | NA |
| Yes | Yes | Yes | No, drowsy | No | No, drowsy |
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
IV normal saline (D5NS 100 mL/h) | + | + | + | + | + | + |
Sodium bicarbonate infusion | + | + | + | + | + | + |
Plasma protein fraction infusion | + | - | - | - | - | - |
Hemodialysis | - | - | - | + | + | + |
Mechanical ventilation | + | + | + | - | - | - |
40 mEq KCl IV Intravenous infusion in 500 mL NSS over 4 or 6 h | + | + | + | + | + | + |
Fomepizole 15 mg/kg IV as loading sode | - | - | - | + | + | + |
Fomepizole 10 mg/kg IV 4 doses/2 days | - | - | - | + | + | + |
Thiamine 100 mg IV/stat | - | - | - | + | + | + |
Ethanol 600 mg/kg IV infusion | - | - | +- | - | - | - |
Omeprazole 40 mg IV daily | + | + | + | + | + | + |
Ranitidine 50 mg IV/stat | - | - | + | - | - | - |
Diazepam 3 mg IV/stat | - | + | + | - | - | - |
sc enoxaparin 4000 iu once a day | + | + | - | - | + | + |
Vasopressor noradrenaline | + | + | + | - | - | - |
Dopamine HCL 40 mcg/kg every 1 h | + | - | - | - | - | - |
Potassium phosphate 21 mmol/day IV | - | + | + | - | - | - |
Magnesium sulphate 2 g/day IV | - | + | + | - | - | - |
KCl 600 mg tab tid PO | - | - | - | - | + | + |
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
AG (mmol/L) | 33.7 | 38.4 | 33.2 | 25.4 | 23 | 23.7 |
Mean ± SD | 33.7 ± 2.87 (died) | 23.7 ± 1.23 (survived) | ||||
p-value | 0.037 (sig) | |||||
OG (mmol/kg) | −18.8 | −29.4 | 19.1 | −15.0 | −23.31 | −13 |
Mean ± SD | 19.10 ± 6.04 (died) | 15 ± 5.47 (survived) | ||||
p-value | 0.024 (sig) |
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
Outcome | Dead | Dead | Dead | Improved | Improved | Improved |
Causes of death | Post-cardiac arrest | Post-cardiac arrest | Post-cardiac arrest | No | No | No |
Anorexic brain damage | Pulmonary arrest | Pulmonary arrest |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alqurashi, G.I.; Alqurashi, F.S.; Alhusayni, K.M.; Falemban, A.H.; Alhindi, Y.Z.; Alsanosi, S.M.; Alzahrani, A.R.; Al-Ghamdi, S.S.; Ayoub, N. Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia. J. Clin. Med. 2023, 12, 4282. https://doi.org/10.3390/jcm12134282
Alqurashi GI, Alqurashi FS, Alhusayni KM, Falemban AH, Alhindi YZ, Alsanosi SM, Alzahrani AR, Al-Ghamdi SS, Ayoub N. Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia. Journal of Clinical Medicine. 2023; 12(13):4282. https://doi.org/10.3390/jcm12134282
Chicago/Turabian StyleAlqurashi, Ghadi I., Fahad S. Alqurashi, Khalid M. Alhusayni, Alaa H. Falemban, Yosra Z. Alhindi, Safaa M. Alsanosi, Abdullah R. Alzahrani, Saeed S. Al-Ghamdi, and Nahla Ayoub. 2023. "Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia" Journal of Clinical Medicine 12, no. 13: 4282. https://doi.org/10.3390/jcm12134282
APA StyleAlqurashi, G. I., Alqurashi, F. S., Alhusayni, K. M., Falemban, A. H., Alhindi, Y. Z., Alsanosi, S. M., Alzahrani, A. R., Al-Ghamdi, S. S., & Ayoub, N. (2023). Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia. Journal of Clinical Medicine, 12(13), 4282. https://doi.org/10.3390/jcm12134282